Acthar and Cyclophosphamide drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Acthar (corticotropin) and Cyclophosphamide (cyclophosphamide). Common drug interactions include mucosal inflammation among females and asthenia among males.

The phase IV clinical study analyzes what interactions people have when they take Acthar and Cyclophosphamide. It is created by eHealthMe based on reports of 19 people who take the same drugs from the FDA, and is updated regularly.

What is Acthar?

Acthar has active ingredients of corticotropin. eHealthMe is studying from 4,948 Acthar users. Check the latest studies of Acthar.

What is Cyclophosphamide?

Cyclophosphamide has active ingredients of cyclophosphamide. It is often used in multiple myeloma. eHealthMe is studying from 185,240 Cyclophosphamide users. Check the latest studies of Cyclophosphamide.



On Jul, 13, 2026

19 people who take Acthar and Cyclophosphamide together, and have interactions are studied.

Acthar and Cyclophosphamide drug interactions.

What are the common drug interactions of Acthar and Cyclophosphamide, by gender? *:

female:

  1. Mucosal inflammation (infection of mucous membrane)
  2. Musculoskeletal chest pain (pain in chest muscle or nerve or bones)
  3. Myoclonus (a brief, involuntary twitching of a muscle or a group of muscles)
  4. Nasal congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels)
  5. Skin irritation
  6. Infusion site pruritus (severe itching at infusion site)
  7. Infusion site rash
  8. Infusion site urticaria (rash of round, red welts on the skin at infusion site)
  9. Tooth disorder (tooth disease)
  10. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)

male:

  1. Asthenia (weakness)
  2. Bladder cancer recurrent
  3. Renal failure (kidney dysfunction)
  4. Weight increased
  5. Blood albumin decreased
  6. Blood pressure decreased
  7. Disease recurrence
  8. Fluid retention (an abnormal accumulation of fluid in the blood)
  9. Generalised oedema (swelling all over the body)
  10. Haemorrhage (bleeding)

What are the common drug interactions of Acthar and Cyclophosphamide, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Neuropathy peripheral (surface nerve damage)
  2. Nocardiosis (an infectious disease affecting either the lungs or whole body)
  3. Pancreatitis acute (sudden inflammation of pancreas)
  4. Granuloma (a small area of inflammation due to tissue injury)
  5. Inflammation
  6. Leukaemoid reaction (elevated white blood cell count, or leukocytosis, that is a physiological response to stress or infection)
  7. Normochromic normocytic anaemia (forms of anaemia in which the average size and haemoglobin content of the red blood cells are within normal limits)
  8. Posterior reversible encephalopathy syndrome (posterior reversible encephalopathy syndrome (pres), also known as reversible posterior leukoencephalopathy syndrome (rpls), is a syndrome characterized by headache, confusion, seizures and visual loss)
  9. Abdominal abscess (collection of pus in abdomen)
  10. Confusional state

20-29:

  1. Blood albumin decreased
  2. Generalised oedema (swelling all over the body)
  3. Renal failure (kidney dysfunction)

30-39:

  1. Drug ineffective

40-49:

  1. Speech disorder
  2. Swelling face
  3. Viith nerve paralysis
  4. Viral infection
  5. Abasia (inability to walk)
  6. Aphasia (damage to the parts of the brain that control language)
  7. Asthenia (weakness)
  8. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
  9. Drooling (drop saliva uncontrollably from the mouth)
  10. Dysphagia (a condition in which swallowing is difficult or painful)

50-59:

  1. Abdominal distension
  2. Abdominal pain
  3. Benign breast neoplasm (benign (non-cancerous) tumours of the breast)
  4. Bone loss
  5. Cardiac failure congestive
  6. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
  7. Chills (felling of cold)
  8. Crepitations (noises are produced by the rubbing of parts one against the other)
  9. Cyst (a closed sac)
  10. Deformity (disfigurement)

60+:

n/a

What are the existing conditions these people have? *

  1. Immunodeficiency Common Variable: 7 people, 36.84%
  2. Nephrotic Syndrome (kidney disease with proteinuria, hypoalbuminemia, and oedema): 3 people, 15.79%
  3. Systemic Lupus Erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue): 2 people, 10.53%
  4. Nocardia Infection (a bacterial infection that usually starts in the lungs. it may spread to other organ systems): 2 people, 10.53%
  5. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 1 person, 5.26%
  6. Hypogammaglobulinaemia (an abnormally low concentration of gamma globulin in the blood and increased risk of infection): 1 person, 5.26%
  7. Dermatomyositis (inflammation of the skin and underlying muscle tissue, typically occurring as an autoimmune condition or associated with internal cancer): 1 person, 5.26%

* Approximation only. Some reports may have incomplete information.

Do you take Acthar and Cyclophosphamide?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Acthar and Cyclophosphamide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Acthar:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Cyclophosphamide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Acthar and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Cyclophosphamide and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on corticotropin and cyclophosphamide (the active ingredients of Acthar and Cyclophosphamide, respectively), and Acthar and Cyclophosphamide (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: